↓ Skip to main content

Mycophenolate Mofetil (CellCept®) in Combination With Low Dose Prednisolone in Moderate to Severe Graves' Orbitopathy

Overview of attention for article published in Frontiers in Medicine, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mycophenolate Mofetil (CellCept®) in Combination With Low Dose Prednisolone in Moderate to Severe Graves' Orbitopathy
Published in
Frontiers in Medicine, February 2022
DOI 10.3389/fmed.2022.788228
Pubmed ID
Authors

Mohammad Taher Rajabi, Seyed Mohsen Rafizadeh, Abbas Mohammadi, Bahram Eshraghi, Nader Mohammadi, Seyedeh Simindokht Hosseini, Mohammad Bagher Rajabi, Mohammad Mohsen Keshmirshekan, Mansoor Shahriari, Seyedeh Zahra Poursayed Lazarjani, Mohammad Mehdi Parandin

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 18%
Student > Bachelor 1 6%
Student > Master 1 6%
Professor > Associate Professor 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 10 59%
Readers by discipline Count As %
Medicine and Dentistry 4 24%
Arts and Humanities 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Environmental Science 1 6%
Business, Management and Accounting 1 6%
Other 1 6%
Unknown 8 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2022.
All research outputs
#15,818,845
of 23,493,900 outputs
Outputs from Frontiers in Medicine
#3,223
of 6,042 outputs
Outputs of similar age
#291,597
of 520,386 outputs
Outputs of similar age from Frontiers in Medicine
#330
of 616 outputs
Altmetric has tracked 23,493,900 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,042 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 520,386 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 616 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.